Teleflex Incorporated
General ticker "TFX" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $5.3B (TTM average)
Teleflex Incorporated follows the US Stock Market performance with the rate: 44.9%.
Estimated limits based on current volatility of 1.8%: low 124.56$, high 129.10$
Factors to consider:
- Earnings expected soon, date: 2026-10-29 bmo
- Company pays dividends (quarterly): last record date 2026-08-14, amount 0.34$ (Y1.04%)
- Total employees count: 15500 (+9.9%) as of 2025
- US accounted for 59.3% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Market competition, Product liability claims, Regulatory and compliance, Supply chain disruptions, Liquidity and credit risks
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [75.23$, 140.46$]
- 2026-12-31 to 2027-12-31 estimated range: [63.40$, 121.79$]
Financial Metrics affecting the TFX estimates:
- Positive: with PPE of 10.0 at the end of fiscal year the price was neutral
- Positive: 4.60 < Operating profit margin, % of 5.94
- Positive: 4.90 < Operating cash flow per share per price, % of 6.23
- Negative: negative Industry operating income (median)
- Negative: Industry inventory ratio change (median), % of 1.32 > 1.15
- Positive: -0.55 < Return on assets ratio (scaled to [-100,100]) of 0.84
- Positive: 42.26 < Shareholder equity ratio, % of 44.98 <= 49.86
- Negative: Industry operating cash flow per share per price (median), % of 1.58 <= 3.66
- Negative: 1.42 < Interest expense per share per price, % of 1.83
Short-term TFX quotes
Long-term TFX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2,974.49MM | $3,047.32MM | $1,992.71MM |
| Operating Expenses | $2,468.18MM | $2,896.31MM | $1,874.34MM |
| Operating Income | $506.31MM | $151.01MM | $118.37MM |
| Non-Operating Income | $-72.30MM | $-75.53MM | $-93.82MM |
| Interest Expense | $85.01MM | $83.51MM | $100.22MM |
| R&D Expense | $113.63MM | $109.02MM | $144.78MM |
| Income(Loss) | $434.01MM | $75.48MM | $24.55MM |
| Taxes | $76.44MM | $5.32MM | $-33.98MM |
| Other Income(Loss) | $212.81MM | $12.48MM | $-964.17MM |
| Net Income(Loss)* | $356.33MM | $69.67MM | $-905.64MM |
| Stockholders Equity | $4,440.99MM | $4,278.14MM | $3,124.77MM |
| Inventory | $626.22MM | $600.13MM | $404.39MM |
| Assets | $7,532.55MM | $7,097.91MM | $6,947.24MM |
| Operating Cash Flow | $510.64MM | $635.74MM | $340.68MM |
| Capital expenditure | $91.44MM | $126.43MM | $95.24MM |
| Investing Cash Flow | $-621.23MM | $-99.36MM | $-849.19MM |
| Financing Cash Flow | $38.54MM | $-421.93MM | $611.54MM |
| Earnings Per Share** | $7.58 | $1.49 | $-20.30 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.